BHCM
CORZ icon

Brevan Howard Capital Management’s Core Scientific CORZ Stock Holding History

Brevan Howard Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
77,800
-805,632
-91% -$19M 0.01% 720
2026
Q1 		$12.4M Buy
883,432
+594,503
+206% +$10.1M 0.11% 104
2025
Q4 		$4.21M Buy
288,929
+271,431
+1,551% +$4.73M 0.05% 277
2025
Q3 		$314K Sell
17,498
-312,535
-95% -$4.58M ﹤0.01% 1543
2025
Q2 		$5.63M Buy
330,033
+176,513
+115% +$1.77M 0.03% 332
2025
Q1 		$1.11M Sell
153,520
-396,480
-72% -$4.51M 0.01% 456
2024
Q4 		$7.73M Sell
550,000
-201,250
-27% -$2.97M 0.05% 93
2024
Q3 		$8.91M Buy
751,250
+115,027
+18% +$1.19M 0.06% 74
2024
Q2 		$5.92M Buy
636,223
+424,179
+200% +$2.17M 0.05% 77
2024
Q1 		$751K Buy
+212,044
New +$735K 0.01% 344

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Brevan Howard Capital Management's CORZ Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Core Scientific (CORZ) stake by 91% in Q2 2026, selling an estimated $19M and leaving 77,800 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #720.

Brevan Howard Capital Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.4M in Q1 2026. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Brevan Howard Capital Management held 77,800 shares of Core Scientific worth $1.99M as of Q2 2026.
  • Brevan Howard Capital Management sold 805,632 Core Scientific shares in Q2 2026, an estimated $19M.
  • Core Scientific made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #720 holding.
  • Brevan Howard Capital Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Core Scientific position peaked at $12.4M in Q1 2026.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.